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INTRODUCTION 
Herbal medicine are being used by about 80% of the world population primarily 
in the developing countries for primary health care. They have stood the test  for their 
safety, efficacy, cultural acceptability and lesser side effects. The  chemical constituents 
present in them are a part of physiological functions of living flora and hence they are 
believed to have better compatibility with the human body. Ancient literature also 
mentions herbal medicines for age-related disease  namely memory loss, osteoporosis, 
diabetic wounds, immune and liver disorders. 
Herbal medicine scenario in India 
 India is one the 12 mega biodiversity centres having over 45,000 plant species,its 
diversity is unmatched due to the presence of different agroclimatic zones 10 vegtable 
zone and 15 biotic provines. The country has 15,000-18,000 flowering plants, 23,000 
fungi, 2500 algae, 16,000 lichens,1800 bryophytes and 30 million micro-organism. 
The turnover of herbal medicine in  India as over –the counter products,ethical 
and classical formulation and home remedies of Ayurveda,unani,and siddha system of 
medicine is about 1 billion with a meager export of about 80 million.(Psyllium seed and 
husk ,castor and opium)80 % of the export to developed countries are of crude drugs and 
not finished formulations leading to low revenue for the country.  
 Herbal medicine and WHO 
WHO it helped the inclusion of proven traditional remedies in national drug 
policies and regulatory approvals by developing countries .The world health assembly 
continued the debate and adopted a resolution (WHA 42.43) in 1989 that herbal medicine 
is of great importance to the health of individuals  and communities. In  1991 WHO 
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developed guidelines for the assessment of herbal medicine,and same was ratified by the 
6th international conference of drug regulatory authorities held at Ottawa in the same 
year.The salient feature of WHO guidelines are:(1)Quality assessment,ofcrude plant 
materials;plant preparations;finished products.(ii)stability;shelf life.(iii)safety assessment 
and Toxicological studies.(IV)Assesment of efficacy.(1) 
Standardization of  herbal medicine  
In indigenous /traditional system of medicine,the drugs are primarily dispensed as 
water decoction or ethanolic exracts of fresh plant parts, juice and crude powder .Thus 
medicinal plant parts should be authentic and free from harmful materials like 
pesticides,heavy metals,microbial or  radioactive contamination etc.The medicinal plant is 
subjected to a single solvent extraction once or repeatedly or water decoction  or as 
described in ancient texts. The extract should then be checked for indicated biological 
activity in an experimental animal models. The bioactive extracts should be standardized 
on the basis of active principle or major compound along with finger prints.The next 
important step is stabilization of the bioactive extract should undergo regulatory or limit 
safety studies in animals.Determination of the probable mode of action will explain the 
therapeutic profile.The safe and stable herbal extract may be marketed it its therapeutic 
use is well documented in indigenous system of medicine ,as also viewed by WHO. A 
limited clinical trial to establish its therapeutic potential would promote clinical use.The 
herbal medicine developed in this mode should be dispensed as prescription drugs or even 
OTC products depending upon disease consideration . (1,2)  
Cancer  
  Cancer cells divide and grow  uncontrollably forming malignant tumours, and 
invade near by parts of the body . The cancer may also spread to more distance of the 
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body through the lymphatic system(or)blood stream. There are over 200 different known 
cancers that affect humans. 
The  causes of cancer are diverse complex and only partially understood.Many 
things are to increase the risk of cancer 
 including ;Tobacco, Dietary factors,   Certain infections,Radiation,lack of physical 
activity ,Obesity and environmental pollutants. Appoximately 5-10 % of cancers can be 
traced directly to inhertited genetic defects. Many cancers could be prevented by avoid 
smoking, eating more vegetable, fruits and whole grains eating less meat and refined 
carbohydrates, maintaing a healthy weight exercising minimizing sunlight exposure and 
being vaccinated against some infectious diseases. 
Cancer can be detected in number of such ways including the presence of certain 
signs and sysmptoms screening tests medical and imaging-microscopic examination of 
tissue sample. cancer is usually treated with chemotherapy radiation therapy and surgery.  
Types of cancer 
 Breast cancer/cervical cancer 
 Ovarian  cancer  
 Leukemia , lymphoma multiple myeloma cancer 
 Bone  cancer 
 Oral  cancer 
 Mouth   cancer 
 Tongue cancer  
 Thyroid  cancer 
 Throat  cancer 
 Brain  cancer 
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 Skin   cancer  
 Kidney  cancer 
 Urinary Bladder cancer 
 Liver cancer 
 Hepato cellular carcinoma cancer 
 Gall bladder cancer 
 Hodgkin’s lymphoma and Non-Hodgkin’s lymphoma(3) 
Hepatocellular Carcinoma-(4  5  6) 
The liver is the largest organ in the body.cancer affecting the liver may be primary or 
secondary. Hepatocellular carcinoma (HCC) is the commonest primary cancer of the 
liver. It is the sixth commonest malignancy worldwide and the third leading cause of 
cancer-related death. 
Hepatocellular carcinoma has a heterogeneous geographical distribution determined 
mainly by the presence of the risk factors in different parts of the world. It is more 
common in sub-saharan Africa and South-East Asia than North  America and western 
Europe. 
    Hepatitis B virus is the major hepatocarcinogen in Asia and Africa, where the 
infection is acquired early in life and thus becomes persistent  up to 75% of individuals. 
In the western world, Hepatitis C virus (HCV)is the leading cause of HCC, which 
develops in older,and cirrhotic patients. Globally, about 80% of cases of HCC are due to 
underlying chronic hepatitis B and C infection. 
   A distinct feature of HCC is the fact that prognosis is not determined only by the 
tumoral disease but also by the severity of the underlying liver disease. Many patients 
who are diagnosed with HCC have advanced disease and are only candidates for 
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palliative care, contributing to a relatively low reported 5-year survival rates of 
approximately 10%.In high prevalence areas ,many patients  die within 6 months of 
diagnosis. 
Causes 
  The most common risk factor in the United States is alcohol abuse; in the rest of 
the world, Hepatitis B and Hepatitis C are the risk factors responsible for most cases of 
hepatoma. Although these are preventable problems, the incidence of hepatoma is 
actually rising in many countries.In the United States ,due to a large increase in Hepatitis 
C infection several decades ago,the incidence has doubled to over 17,000 cases each year. 
Recent Research has demonstrated that a large part of the increase in hepatoma is due to 
the rise in obesity and diabetes over the past few decades. 
Clinical Features 
Patients who develop HCC usually have no symptoms other than those related to 
their chronic liver disease. Suspicios for HCC should be heightened in patients with 
previously compensated cirrhosis who develop decompensation such as ascites, 
encephalopathy and jaundice.These complications are often associated with extension of 
the tumor in to the hepatic or portal veins or arteriovenous shunting induced by the tumor. 
Some patients may have mild to moderate upper abdominal pain, wight loss, early 
satiety or a palpable mass in the upper abdomen. These symptoms often indicate an 
advanced lesion. 
Symptoms and Sings 
Symptoms such as weakness, fatigue ,weight loss or loss of appetite are 
common.Signs of liver damage may appear as the tumorgrows,such as an increase in 
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abdominal size due to accumulation of fluid around the liver and intestines(called 
ascites)and jaundice,a yellowing of the skin and eyes along with dark urine. Jaundice 
occurs due to the accumulation of bilirubinin in blood(more than 2 mg%)a breakdown 
product of red blood cells that is usually handled by the liver. 
  More severe liver failure may cause internal bleeding and mental changes, 
including confusion or uncontrollable sleepiness(encephalopathy)as the liver is no longer 
able to handle all the harmful chemicals in the blood. Rarely, affected people may 
develop fevers, night sweats or pain. 
Causes 
Cancers are primarly an environmental disease with 90-95% of cases attributed to 
environmental factors and 5-10 %  due to genetics. 
Factors: causes of cancer 
 1.Environmental 
 2.Inherited genetically 
 3.Tobacco 25-30% 
 4.Obesity 30-35% 
 5.infection15-20% 
 6.Radiation(both ionizing and non-ionizing) 10% 
 7.stress  and lack of physical activity 
Chemicals 
 Alcohol and cancer 
 Smoking  and cancer 
 DENA(Diethyl nitrosamine) 
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The incidence of lung cancer is highly correlated with smoking. 
Tobacco smoking is associated with many forms of cancer and causes 90% lung 
cancer. Decades of research has demonstrated the link between tobacco use and cancer in 
the lung, larynx, head, neck, stomach, bladder, kidney, esophagus and pancrease. 
Carcinogens including nitrosamines and polycyclic aromatic hydrocarbon. Millions of 
workers run the risk of developing cancers such as lung cancer and mesothelioma from 
inhaling asbestos fibers and tobacco smoke or leukemia from exposure to benzene at their 
work places. 
Diet and exercise 
Diet physical inactivity and obesity are related to approximately 30-35% cancer 
deaths. Physical inactivity is believed to contribute to cancer risk not only through its 
effects on body weight but also through negative effects on immune system and 
endocrine system.Diet that are low in vegetables fruits and whole grains and high in 
processed (or)red meats are linked with a number of cancers. 
A high salt diet is linked to gastric cancer, aflatoxin B1, a frequent food 
contaminate causes liver cancer ,and betalnut chewing with oral cancer. Gastric cancer is 
more common with intakes of high salt diet . 
Infection 
Viruses are the usual infectious agents that cause cancer but bacteria and parasites 
may also have an effect. A virus that can cause cancer is called an oncovirus, These 
include human papilloma virus β-cell lympho - proliferactive disease and naso pharyngeal 
carcinoma. herpavirus, hepatitis B, and hepatitis c viruses and human T-cell 
leukemias.bacterial infection may also increase the risk of cancer as seen in helicobactor 
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pylori-induced gastric carcinoma. Parasitic infections stongly associated with cancer 
include schistosoma haematobium. 
Physical agents 
Prolonged exposure to ultraviolet radiation f the sun lead to melanoma and other 
skin malignancies. Non-ionozing radio frequency radiation from mobile phones and 
electric power transmission. 
Heredity 
Some of these syndrome include certain in heredity mutations in the genes 
BRCA1,BRCA2 with a more than 75% risk of breast and ovarian cancer.  
Hormones 
 Some hormones play a role in the development of cancer by promoting cell proliferation 
.Insulin like growth factors and their binding protein play a key role in cancer cell 
proliferation ,differentiation and apoptosis suggesting possible involvement in 
carcinogenesis. 
Diagnosis 
Most cancer are initially recognized either because of the appearance of signs or 
through screening, medical tests .These commonly include blood tests x-rays, CT scans 
and endoscopy.. 
Diethyl nitrosamine 
    Diethyl nitrosamine is one of the important environmental carcinogen that 
primarily induced tumors of the liver. because of its relatively simple metabolic pathway 
and potent carcinogenic activity.DEN confers its carcinogenicity through the metabolic 
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activation in the liver microsome causing the releasing of alkylating agents that bind to 
the DNA forming adducts. It has been reported that their biotransformation produces the 
promutagenic adducts O6-ethyldeoxyguanosine,O4 and O6-ethyldeoxythymidine and 8-
hydroxyguanine (8-OHG)that play a role in the initiation step of rat liver carcinogenesis 
and generation of superoxide radicals, paralleled by lipid peroxidation reaction. lipid 
peroxidation (LPO) is regarded as one of the basic mechanism of cellular damage caused 
by freeradicals. Free radicals react with lipid causing peroxidation resulting in release of 
products such as malandiodehyde (MDA),hydrogen(H2 O 2) and hydroxyl radicals 
(OH).ROS including oxygen, hydrogen peroxide and hydroxyl radical(OH) play in 
important role in carcinogenesis.  
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CHAPTER II 
LITERATURE SURVEY 
Ethno medicinal uses: 
1. Leaves are used to treat cough with, nausea, cancer, mouth sore, liver disease 
hypertension, lumbago and sciatica 
2. Root is used for purgative 
3. leaves are used in cancer treatment 
4. Decoction of leaves are used externally for urticaria. Decoction of the bark is used 
for bronchial catarrh.(7)  
 
Tai  et al.,(2013) have reported the antiviral activity of Phyllanthus reticulates  against 
human immuno deficiency virus type1(HIV-1) which is the major cause for AIDS. (8)   
Chouhan et al.,(2013)have reported the photochemical analysis, antioxidant and anti-
inflammatory activities of Phyllanthus simplex. (9) 
Hansakul et al,(2012have reported the anti tumor and Induction of cancer cell apoptosis  
effect of  Phyllanthus emblica.(10)  
Patel et al., (2012) have reported the ethano medicinal uses  phytochemistry and 
,pharmacological evaluation of Phyllanthus amaraus.(11)  
Dang  et al.,(2012) have reported the anti-inflammatory activity of Phyllanthus emblica, 
and Cyprus rotundus in acute models of inflammation.(12) 
Zhu  et al .,(2012) have studies on Isolation and x-ray crystal structure of  securinega-
tybe alkaloid from Phyllanthus niruri Linn. Studied on analgesic activity, antipyretic 
potential of Phyllanthus amarus. (13) 
Mazumder  et al.,(2010)) have reported new phthalates from Phyllanthus muellerianus 
(Euphorbiaceous) (14) 
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Pagare  et al.,(2010) studied on protocol for callus culture of Phyllanthus amarus schum 
and Thonn and possibility of use of callus  culture in production of phyllanthin and 
hypophyllanthin.(15) 
Chattopadhyay p et al.,(2010) have reported the Increase of insulin activity by 
Phyllanthus amaras Linn on liver cell regeneration in albino rats.(16) 
Fan   et al.,(2009) have reported  antioxidant and inflammatory mediator’s growth 
inhibitory effect of compound isolated from Phyllanthus urinaria.(17) 
Garg   et  al.,(2008) have reported anti diabetic potential of Phyllanthus urinaria in 
albino rats.(18) 
kumar  et al.,(2008)have reported the antidiabetic potential of Phyllanthus reticulates in 
alloxan-induced diabetic in mice.(19) 
Karthikeyan  et al.,(2008)have reported the regeneration of Phyllanthus niruri L.from 
shoot tip and nodal explants.(20) 
Harikumar  et al.,(2007) have reported the antibacterial activity of Phyllanthus and 
curcumin.(21) 
Kumaran  et al.,(2007) have reported the anti oxidant activity of polyphenol from 
Phyllanthus debilis wild.(22) 
Garg  et al.,(2007) have reported the antidiabetic and antioxidant potential of Phyllanthus 
fraternus in alloxan induced diabetic in animals.(23) 
Bos  et al.,(2006) have reported the lignans from cell suspension culture o fPhyllanthus 
niruri an Indonesian medicinal plant.(24) 
Balakumbahan. et al.,(2006) have reported the effect of inorganic and biofertilizers on 
biomass and alkaloid yield of Phyllanthus amarus.(25) 
Sailaja  et al.,(2006) have reported the protective effect of Phyllanthus fraternus against 
allyl alcohol- induced oxidative stress in liver mitochondria.(26) 
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Zhang Y et al.,(2004) have reported the antiproliferative activity of the main constituents 
from Phyllanthus emblica.(27) 
Srinivasa  et al.,(2004) have reported the anti cancer and antiviral activity of Phyllanthus 
maderasapatensis . HPTLC method was used for the quantification of gallic acid and 
ellagic acid content this plant.(28) 
Al-re haily   et al.,(2003) have reported the gastroportective  effect of Phyllanthus 
emblica in-vivo test model in rats (29) 
Rajeskumar  et al.,(2001) have reported the Phyllanthus amarus extract of 
administration increase the life span of rats with hepatocellular carcinoma.(30) 
Suganya L.et  al.,(2001)have reported the Phyllanthus emblica extract of influecnce on 
dermal wound healing in rats. (31) 
Dep S. et al.,(1998) have reported the Phyllanthus amarus  extract of  simple thinlayer 
chromatograhy-densiometric methods for the estimatio of the two lignans phyllanthin, 
hypophyllanthin and polyherbal formulation (32)  
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AIM AND SCOPE OF THE PRESENT STUDY 
 
The ethanomedicinal information of Phyllanthus acidus indicates that it was used 
as an emetic cathartic,antihypertensive,anti asthmatic, liver tonic and also to treat 
cancer.Phyllanthu acidus as well as other species of Phyllanthus emblica were used in 
traditional medicine for the treatment of various type of cancer.The root of this plant was 
used to treat psoriasis .The leaf of this plant was also found to posses anti-inflammatory 
,antinociceptive antioxidantant,hepatoprotective ,hypotensive and antidiabetic activity. 
Antibacterial and cytotoxicactivity were also reported in this plant.(33-34) 
Phyllanthosols A and B from fruits of this plant has already been reported for 
anticancer activity. 
Pharmacognostical studies have not yet been reported in the leaves of this plant. 
Leaves of this plant have not yet been reported for liver cancer studies.   
Hence the present work has been designed to carry out the following studies on the 
the leaves Phyllanthus acidus. 
 Pharmacognostical studies 
 Preliminary phytochemical screening of crude drug and ethanolic extract 
ofPhyllanthus acidus(EEPA) 
 Estimation of total phenolic,total tannin and flavonoid content of EEPA 
 Phytochemical evaluation of EEPA by TLC and HPLC 
 Quantification of active principles present in this plant extracts. 
 Screening of the EEPA for the following pharmacological activities; 
 In-vitro antioxidant activity by DPPH radical and Hydrogen peroxide scavenging 
assay .In vivo anticancer effect of EEPA against DEN induced hepatocellular 
carcinoma in  rats.  
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CHAPTER - IV 
PHARMACOGNOSTICAL STUDIES 
SECTION A 
 PLANT PROFILE (35-36) 
 Biological source       :  Phyllanthus acidus L 
 Family                                 :  Euphorbiaceae 
 Synonyms                           :  Phyllanthus distichus mull Arg, Cicca  
   acida merr, Cicca disticha L , 
Averrhoa    acid L. 
Systemic Position: 
 Kingdom                       :  Plantae 
 Subkingdom                         :  Tracheobionta 
 Superdivision              :  Spermatophyte 
 Division                       :  Magnoliophyta 
 Class                             :  Rosidae 
 Order                           :  Euphorbiales 
 Family                         :  Euphorbiaceae  
 Genus                         :  Phyllanthus  
 Species                     :    acidus 
 English  name            :   Star goose berry, Malay goose berry 
 Common name :  Star goose berry  
 Hindi                                       :  Harfarauri 
 Marathi                      :  Harpharori 
 Konkani : Raiamvali 
 Manipuri :  Gihori 
 Tamil                          :  Aranelli 
 Urudhu :  Harfarauri 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIG  : 1 . Herbarium of  Phyllanthus acidus 
  
 
 
 
 
 
 
 
 
 
 
 
FIG  : 2 . Leaves of  Phyllanthus acidus 
 
  
 
 
 
 
 
 
 
 
 
 
FIG:3 . Phyllanthus acidus of tree 
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FIG:8 .Flowers of Phyllanthus acidus 
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Geographical distribution& occurrence 
This tropical (or) subtropical species is found throughout Asia and also in the 
Caribbean region. The tree is common in Guam in Indonesia. In South Vietnam this plant 
is called as chum ruot and in India it is called as chalmeri and harpharoi. 
Description of the plant   
This plant bears alternate leaves which are ovate with short petiole. flowers are in 
little clusters and bears pale yellow colour. the fruit is sub-spherical with 6 to 8 ribs and 
pale yellow color. 
SECTION-B 
MICROSCOPICAL STUDIES OF THE LEAVES  
MATERIALS AND METHODS (37-38) 
 
Phyllanthus acidus as collected from Vadakkikottai village, Thanjavur and 
identified by Taxonomist. 
Petiole and leaf were fixed in FAA solution (70% ethyl alcohol, formalin and 
acetic acid in the ratio of 90 ml: 5 ml: 5 ml).  The materials were left in the fluid for three 
days and then they were washed in water and dehydrated with tertiary butyl alcohol.  
Paraffin wax was filtered and the specimens were embedded in wax for sectioning. 
Transverse sections of petiole and leaf were taken using microtome and stained 
with toluidine blue. All slides, after staining in toluidine blue, they were dehydrated by 
employing graded series of ethyl alcohol (70 %, 90 %, 100 % alcohol) and xylol-alcohol 
(50-50) and passed through xylol and mounted in DPX mountant (Johansen, 1940).   
Clearing of leaves for studying stomatal number and stomatal index was done by 
using 5% sodium hydroxide along with chlorinated soda solution supplemented with 
gentle heat.  Quantitative microscopy was carried out and values were determined as per 
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the procedure given in Wallis (1997). Photomicrographs were taken with the help of 
Nikon Eclipse E200 Microscope.  
The microscopic features of the various parts of the leaf are presented in                 
Fig. 1 to 7 
SECTION-C 
QUANTITATIVE MICROSCOPY 
This is useful for identification, characterization, and standardization of crude 
drugs. A clear idea about the identity and characteristic features of the drug can be 
obtained after several numbers of determinations; the characteristic’s number obtained is 
noted and compared with a standard value to find out whether it is within the range.  
STOMATAL NUMBER AND STOMATAL INDEX [39-40] 
Stomatal number  
The average number of stomata present in 1 square millimeter area of   each 
surface of a leaf epidermis is termed as stomatal number .[41] 
Stomatal index  
The stomatal index is the percentage of the number of stomata formed by the total 
number of epidermal cells including stomata, each stoma being counted as one cell. 
Determination of stomatal number and stomatal index 
` To study the stomatal morphology (type of stomata), stomatal number and 
stomatal index of leaf, the leaf was subjected to epidermal peeling by partial maceration 
employing the Jeffrey’s maceration fluid.  
A fragment was transferred in to microscopic slide and the mount of lower and 
upper epidermis was prepared with a small drop of glycerol solution at one side of the 
cover slip to prevent the slide from drying. The slide was examined under 45X objective 
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and 10X eye piece to which a microscopical apparatus was attached. Circle (O) like mark 
was marked on the drawing paper for each stoma. The average number of stomata/square 
mm for each surface of the leaf was calculated and their values are tabulated in table 1.  
For stomatal index, the glycerin mounted leaf peeling as mentioned above was 
made and circle (O) like mark for each stomata and a cross (X) like mark for each 
epidermal cells was marked on the drawing paper. The stomatal index was calculated by 
using the formula,  
Stomatal index        S.I =  ×100 
Where S = Number of stomata in 1 sq mm area of leaf and E = Number of 
epidermal cells (including trichomes) in the same area of leaf. The values are tabulated in 
table 1. 
VEIN ISLET NUMBER AND VEIN TERMINATION NUMBER 
The term vein islet is used to denote the minute area of photo synthetic tissue 
encircled by the ultimate division of the conducting strands. The number of vein islets per 
square mm area is called vein- islet number. 
Vein termination number may be defined as the number of vein terminations 
present in one square mm area of the photosynthetic tissue. [42] 
Determination of Vein Islets and Vein Terminations 
The fragment of leaf lamina with an area of not less than 1 sq mm excluding the 
midrib and the margin of the leaf was taken. The fragments of leaf lamina were cleared 
by heating in a test tube containing chloral hydrate solution on a boiling water bath until 
clear. The cleared fragments were stained with safranin solution and a temporary mount 
was prepared with glycerol solution. The stage micrometer placed on the microscopic 
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stage, examined under 10X objective and 10X eye piece and an area of 1 sq mm square 
was drawn. The cleared leaf piece was placed on the microscope stage, the vein islets and 
vein terminals included in the square was drawn. 
The number of vein islets and terminals within the square including those over 
lapping on two adjacent sides and excluding those intersected by others two sides were 
counted. The results obtained in the number of vein islets and terminals in1 sq mm were 
tabulated in table 1. 
PALISADE RATIO 
Palisade ratio is the average number of palisade cells under one epidermal cell. It 
is another important criterion for identifications and evaluations for crude drugs. Since it 
is constant for a plant species which is useful to differentiate the species and does not 
altered based on geographical variation [40]. 
Determination of Palisade Ratio 
Epidermal peeling was done by partial maceration by Jeffery’s maceration fluid 
were prepared. A fragment was transferred into a microscopical slide and the mount of 
upper epidermis was prepared with a small drop of glycerol on one side of the cover slip 
to prevent the preparation from drying. The same was examined under 45X objective and 
10X eye piece. Four adjacent epidermal cells were traced; focusing gently downward to 
bring the palisade cells into view and sufficient palisade cells to cover the outlined four 
epidermal cells were then traced. The palisade cells under the epidermal cells were 
counted and calculate the palisade ratio by using the following formula and the results 
were tabulated in table 1. 
Palisade ratio = Avarage number of palisade cells beneath the 4 epidermal cells/4 
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SECTION – D 
PHYSICAL PARAMETERS 
POWDER ANALYSIS 
The behavior of the powder with different chemical reagents was carried out as 
per standard procedure [43]. The observations are presented in table 2. 
Fluorescence analysis  
The fluorescent analysis of the drug powder as well as the plant extracts of  
Phyllanthus acidus were carried out and the observations are tabulated in tables 3 & 4. 
STANDARDIZATION PARAMETERS [40] 
Ash values, loss on drying, foreign organic matter and extractive values etc. are 
the important physical parameters for the standardization of plant materials. The method 
given in Indian Pharmacopoeia, 1996 and WHO guidelines, 1998 were followed to 
determine total ash, water-soluble ash, acid-insoluble ash and loss on drying. The 
percentages of extractive values for different solvents were also determined for the leaves 
of this plant. 
Determination of foreign organic matter  
The part of organ or organs other than those specified in the definition or 
description of the crude drug is defined as foreign organic matter.  
An accurately weighed 100 g of air dried coarse drug was spread out as a thin 
layer. The sample drug was inspected with the unaided eye or with the use of 6X lens and 
the foreign organic matter was separated manually as completely as possible and 
weighed. The percentage of foreign organic matter was calculated with reference to the 
weight of the drug taken. The result is presented in table 5. 
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Determination of Moisture Content (Loss on Drying)  
An accurately weighed 10 g of coarsely powdered drug was placed in a tarred 
evaporating dish. Then the dish was dried at 105oC for 5h and weighed. The drying and 
weighing was continued at one hour intervals until the difference between the two 
successive weighing is not more than 0.25%. The loss on drying was calculated with 
reference to the amount of powder taken. The readings are tabulated in table 5.  
Determination of Ash values [44]   
Ash Content   
 The residue remaining after incineration is the ash content of crude drug, which 
simply represents inorganic salts naturally occurring in the drug or adhering to it or 
deliberately added to it as a form of adulteration. 
Determination of Total Ash (45) 
An accurately weighed 3 g of air dried coarsely powdered drug was taken in a tarred 
silica crucible and incinerated at a temperature not exceeding 450oC, until free from 
carbon then allowed to cool and weighed. The percentage of ash was calculated with 
reference to the air dried drug.   
Determination of Acid Insoluble Ash 
The total ash obtained from the previous procedure was mixed with 25mL of 2M 
hydrochloric acid and boiled for 5min in a water bath, and then the insoluble matter was 
collected in an ashless filter paper and washed with hot water, dried and ignited for 15min 
at a temperature not exceeding 450oC, cooled in  a desiccator and weighed. The 
percentage of acid insoluble ash was calculated with reference to the air dried drug.     
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Determination of Water Soluble Ash 
The total ash obtained from the previous procedure was mixed with 25mL of 
water and boiled for 5min in a water bath, and then the insoluble matter was collected in 
an ashless filter paper and washed with hot water, dried and ignited for 15min at a 
temperature not exceeding 450oC, cooled in desiccators and weighed. The insoluble 
matter was subtracted from the weight of the total ash; the difference in weight represents 
the water soluble ash. The percentage of water soluble ash was calculated with reference 
to the air dried drug. 
The values in respect of the total ash values, acid insoluble ash, water soluble ash 
and water insoluble ash are tabulated in table 5. 
Determination of Extractive Values  
Extractive values used to determine the amount of active principle or phyto 
constituents present in the given amount of plant materials, when extracted with suitable 
solvents. Determination of extractable matter determines the amount of active 
constituents extracted with solvents from a given amount of medicinal plant material and 
herbal formulation. The extraction of crude plant materials with suitable solvents yields a 
solution containing different phyto constituents. Composition of the phyto constituents in 
a particular solvent depends upon the nature of drugs and solvents used. This is used to 
provide preliminary information on the quality of particular sample. 
Determination of ethanol soluble extractive       
An accurately weighed 5 g of the air dried coarsely powdered drug was macerated 
with 100mL of ethanol in a closed flask for 24h, shaking frequently during the first 6h 
and allowed to stand for 18h. Thereafter filtered rapidly, taking precautions against loss 
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of ethanol. Then evaporate 25mL of the filtrate to dryness in a tarred flat bottomed 
shallow dish dry at 105oC and weighed. The percentage of ethanol soluble extractive was 
calculated with reference to the air dried drug. 
Determination of water soluble extractive      
The procedure adopted for ethanol soluble extractive value was followed for the  
determination of water soluble extractive, Chloroform soluble extractive, benzene 
soluble extractive, acetone soluble extractive value, and ethylacetate soluble extractive 
value and the reported  presented in the  table.  
Microscopical characters of Powder of Phyllanthus acidus 
Showe the presence of characters Paracytic stomata, Paraenchyma, collenchyma, 
Phloem, vessels, fibres. 
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CHAPTER V 
PHYTO CHEMICAL STUDIES 
 
Phytochemical studies are carried out for the separation, purification and 
identification of the secondary metabolites  present in medicinal plants. 
Collection and aunthentication 
The leaves of Phyllanthus acidus  was collected in an around Thanjavur and 
authenticated by taxonomist. The shadow dried leaves were powdered and then subjected 
to the following preliminary phytochemical studies. 
SECTION- A 
  ORGANOLEPTIC EVALUATION 
 Nature - Coarse powder 
 Color  - Green 
 Odour  - Characteristic odour 
 Taste  - Bitter followed by astringent taste 
                                           SECTION-B 
               QUALITATIVE CHEMICAL ANALYSIS (45-46) 
The various extracts of Phyllanthus acidus were subjected to qualitative chemical 
analysis. in  order to detect the presence of steroids, terpenoids, flavones,anthraquinones 
sugars, quinones,phenols,and tannins . The results were tabulated in table -7 
1. Test for sterols 
The powdered leaf was first extracted with petroleum ether and evaporated to a 
residue. Then the residue was dissolved in chloroform and tested for sterols. 
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a. Salkowski’s test 
A few drops of concentrated sulphuric acid were added to the above solution, shaken 
well and set aside. The lower chloroform layer of the solution turned red in color 
indicating the presence of sterols. 
b. Liebermann – burchard’s test 
To the chloroform solution a few drops of acetic anhydride and 1 mL of concentrated 
sulphuric acid were added through the sides of the test tube and set aside for a while. At 
the junction of two layers a brown ring was formed. The upper layer turned green 
indicating the presence of sterols. 
2. Test for carbohydrates 
a. Molisch’s test 
The extract of the powdered leaf was treated with 2-3 drops of 1% alcoholic -
naphthol and 2 mL of concentrated sulphuric acid were  added along the sides of the test 
tube. 
A purple color indicating the presence of carbohydrates. 
Fehling’s test 
The extract of the powdered leaf was treated with Fehling’s solution I and II and 
heated on a boiling water bath for half an hour.  
Red precipitate was obtained indicating the presence of free reducing sugars. 
c. Benedict’s test 
The extract of the powdered leaf was treated with equal volume of Benedict’s 
reagent  A red precipitate was formed indicating the presence of reducing sugar. 
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3. Test for proteins 
a. Millon’s test  
A small quantity of acidulous – alcoholic extract of the powdered drug was heated 
with Millon’s reagent. 
White precipitate turned red on heating indicate the presence of proteins.  
b. Biuret test 
To one portion of acidulous – alcoholic extract of the powdered drug one ml of 10 % 
sodium hydroxide solution and one drop of dilute copper sulphate solution were added.  
Violet color was obtained indicating the presence of proteins. 
4. Test for alkaloids 
a. About 2 gm of the powdered material was mixed with 1gm of calcium 
hydroxide and 5 mL of water into a smooth paste and set aside for 5 minutes. It was then 
evaporated to dryness in a porcelain dish on a water bath. To this 200 mL of chloroform 
was added, mixed well and refluxed for half an hour on a water bath. Then it was filtered 
and the chloroform was evaporated. To this 5 mL of dilute hydrochloric acid was added 
followed by  2 mLof each of the following reagents.  
a) Mayer’s test: 
To small quantity of the extract  Mayer’s reagent was added. No cream colour 
precipitate indicates the absence of alkaloids. 
b) Dragen dorff”s tesr 
To small quantity of the extract  Dragendorff’s reagent was added. No Orange 
brown precipitate indicates the absence of alkaloids. 
c) Wagner’s test:   
 To small quantity of extracts  Wagner’s reagent was added . No Reddish brown 
precipitate indicates the absence of alkaloids.    
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d) Hager’s test: 
To small quantity of extract  Hager’s reagent was added . No Yellow precipitate 
indicates the absence of alkaloids. 
e) Test for purine group (murexide test) 
The residue obtained after the evaporation of chloroform as described in (a) was 
treated with 1mL of hydrochloric acid in a porcelain dish and 0.1 gm of Potassium 
chlorate was added and evaporated to dryness on a water bath. Then the residue was 
exposed to the vapour of dilute ammonia solution. No purple Color was obtained 
indicating the absence of purine group of alkaloids. 
5. Test for glycosides 
a) Borntrager’s test 
The powdered leaf was boiled with dilute sulphuric acid, filtered and to the filtrate 
benzene was added and shaken well. The organic layer was separated to which ammonia 
solution was added slowly. 
Ammoniacal layer showed the pink colour indicating the presence of 
anthraquinone glycosides. 
b) Modified borntrager’s test 
      About 0.1g of the powdered drug was boiled for 2 minutes with dilute hydrochloric 
acid and few drops of ferric chloride solution, filtered while hot and cooled. The filtrate 
was then extracted with benzene and the benzene layer was separated. Equal volume of 
dilute ammonia solution was added to the benzene extract. 
Pink color was observed in ammoniacal layer showing the presence of 
anthraquinone glycosides. 
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c) Test for cardiac glycosides(for deoxysugar) 
i) Keller kiliani test 
 About 1g of the powdered leaf was boiled with 10 mL of 70  % alcohol for 2 
minutes, cooled and filtered. To the filtrate 10 mL of water and 5 drops of solution of lead 
subacetate were added and filtered, evaporated to dryness. The residue was dissolved in 3 
mL of glacial acetic acid. To these 2 drops of ferric chloride solution was added. Then 3 
mL of concentrated sulphuric acid was added to the sides of the test tube carefully and 
observed. 
Reddish brown layer was observed indicating the presence of deoxysugars of 
cardiac glycoside 
d) Test for cyanogenetic glycosides 
  Small quantity of the powder was placed in a stoppered conical flask with just 
sufficient water, to cover it. A sodium picrate paper strip was inserted through the stopper 
so that it was suspended in the flask and it was set aside for 2 hours in a warm place. 
No brick red color was produced on the paper indicating the absence of  
cyanogenetic glycosides. 
6. Test for saponins 
              About 0.5 g of the powdered drug was boiled gently for 2 minutes with 20mL of 
water and filtered while hot and allowed to cool. 5 mL of the filtrate was then diluted with 
water and shaken vigorously.  Frothing was produced indicating the presence of saponins. 
7. Test for tannins 
           A small quantity of the powdered drug was extracted with water. To the aqueous 
extract few drops of ferric chloride solution was added. 
      Bluish black color was produced indicating the presence of tannins. 
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8. Test for flavonoids 
a. Shinoda’s test 
A little of the powdered drug was heated with alcohol and filtered. To the test 
solution magnesium turnings and few drops of concentrated hydrochloric acid were 
added. Boiled for five minutes. 
     Red colour was obtained indicating the presence of flavonoids. 
b. Alkali test 
To the small quantity of test solution 10 % aqueous sodium hydroxide Solution 
was added.  Yellow orange color was produced indicating the presence of flavonoids.  
c. Acid test 
To the small quantity of test solution, few drops of concentrated sulphuric acid 
were added. Yellow orange colour was obtained indicates the presence of flavonoids. 
9. Test for terpenoids 
 A little of the powdered leaf was extracted with chloroform and filtered. The 
filtrate was warmed gently with tin and thionylchloride. Pink color solution appeared 
which indicated the presence of terpenoids. 
10. Test for the absence of volatile oil 
Weighted quantity (250 gm) of fresh leaves were extracted and subjected to hydro 
distillation using volatile oil estimation apparatus. 
          Volatile oil was  not obtained indicating the of absence of volatile oil. 
11. Test for mucilage  
            Few ml of aqueous extract prepared from the powdered crude drug was treated 
with ruthenium red. Red colour was produced indicating the presence of mucilage. 
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SECTION – C 
QUANTITATIVE ESTIMATION OF PHYTO-CONSTITUENTS 
In quantitative estimations, Secondary  metabolites like phenolic compounds 
tannin and flavonoids  present in the extracts were quantified  using standard Procedure  
reference marker compounds. 
Preparation of extracts 
Preparation of ethanolic extract of Phyllanthus acidus 
The air dried  powdered plant material of leaves of Phyllanths acidus was passed 
through seive no- (10/40) Coarsely powdered Plant material  was defatted with petroleum 
ether (60-80˚c) for three days by triple maceration. The defatted marc was extracted with 
70% ethanol by triple maceration and filtered. The filtrate was concentrated under 
reduced pressure to obtain a solid residue which was dark green in colour. 
I)  Determination of total phenolic Content(47-48) 
Phenolic compounds comprises of Secondary metabolites like tannins, 
anthraquinones, flavonoids and coumarins. These compounds  have at least one hydroxyl 
group attached to a benzene ring. Phenolic compounds have been reported to have 
multiple pharmacological effects, including antioxidant activity. 
Principle 
  All the phenolic compounds are oxidized by the Folin-Ciocalteu Reagent. This 
reagent, which is reduced during oxidation of the phenolic substances, into a mixture of 
blue molybdenum and tungsten oxides. 
                  The blue colour produced has a maximum absorption at about 750-760 nm. 
The absorption is proportional to the quantity of oxidized phenolic compounds. 
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
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Reagents required  
a) Folin Ciocalteu Reagent (1N) 
The Folin Ciocalteu reagent is a mixture of phosphomolybdate and 
phosphotungstate.  Commercially available Folin Ciocalteu Reagent (2N) was 
diluted with an equal volume of distilled water. The resultant solution was kept in 
a brown color bottle and stored in refrigerator at 4 ºc. 
b) Sodium carbonate solution (10 %) 
c) Standard gallic acid solution. 
Procedure 
           About 1mL (1 mg/ mL and o.5 mg/mL) of ethanolic extracts of EEPA and 0.5ml 
of Folin Ciocalteu reagent (1N) were added and allowed to stand for 15 minutes. Then 
1mL of 10% sodium carbonate solution was added to the above solution. Finally the 
mixtures were made upto 10 mL with distilled water and allowed to stand for 30 minutes 
at room temperature and total phenolic content  was  determined by 
spectrophotometrically at 760 nm wavelength. 
             The calibration curve was generated by preparing Gallic acid at different 
concentrations (2, 4, 6, 8, and 10µg/mL). The reaction mixture without sample was used 
as blank. Total Phenolic content is expressed in terms of mg of Gallic acid equivalent per 
gm of extract (mg GAE/g). The results are tabulated in table(9)  and the calibration graph 
was presented.(FIG.20) 
II) Total flavonoid determination (49-44) 
The different classes of flavonoid are catechins, leucoanthocyanidins, flavanones, 
flavones, anthocyanidins, flavonols, chalcones, aurones and  isoflavones. They are 
reported to have various pharmacological activities like antioxidant, antiiflammatory and 
anticancer. 
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Principle 
The aluminum chloride colorimetric technique was used for estimation of total 
flavonoid estimation. Aluminum ions form stable complexes with C4 keto group and 
either to C3 or C5 hydroxyl groups of flavones and flavonols in acidic medium. It also 
forms acid labile complexes with ortho hydroxyl groups in the A or B rings of flavanoids. 
These complexes showed a strong absorption at 415nm which is used for the estimation 
of flavonoids.  
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents required 
 10% aluminum chloride 
 1M potassium acetate 
Procedure 
1mL(Img/ImL and 0.5mg/mL) of ethanolic extracts of EEPA was  taken and 
0.1mL of aluminum chloride solution, 0.1mL of potassium acetate solution and 2.8mL of 
ethanol were added and the final volume was then made up to 5mL with distilled water. 
After 20 min the absorbance was measured at 415nm.  
A calibration curve was constructed by plotting absorbance reading of quercetin at 
different concentrations. The sample without aluminium chloride was used as a blank. 
The total flavonoid content in the extract was expressed as milligrams of quercetin 
equivalent per gram of extract and the results are tabulated (10)(FIG.21) 
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Total tannin determination (50-51) 
Principle  
Total tannin content of extract was determined by Folin Denis reagent method.                
Tannin like compounds reduces phosphotungstomolybdic acid in alkaline solution 
to produce a highly coloured blue solution. The intensity of which is proportional to the 
amount of tannins and it was estimated by spectrophotometer at 700 nm. 
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents required 
a) Folin Denis Reagent ( sodium tungstate 100 g and phospho molybdic acid20gwere 
dissolved in distilled water 750 ml along with phosphoric acid 50 ml.  
b) The mixture was refluxed for 2 hours and volume was made upto 1 litre with 
distilled water )  
c) Sodium carbonate solution (10%) 
d) Standard tannic acid solution. 
Procedure  
           0.2mL of (1mg/mL) of ethanolic extract of EEPA was made upto1ml with distilled 
water. Then add 0.5 mL of Folin Denis reagent and allowed to stand for 15 mins, then 
1mL of sodium carbonate solution was added to the mixture and it was made upto 10mL 
with distilled water. The mixture was allowed to stand for 30mins at room temperature 
and the tannin content was determined spectrophotometrically at 700 nm.  
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The calibration curve was generated by preparing tannic acid at different 
concentration (4, 8, 12, 16, 20µg/ml). The reaction mixture without sample was used as 
blank. The total tannin content in the leaf extract was expressed as milligrams of tannic 
acid equivalent per gm of extract. The results were tabulated in table 11. (FIG 22.) 
                             SECTION –D 
Identification and estimation of Apigenin in EEPA by HPLC 
HPLC studies of EEPA was carried out in order to identify and quantify the active 
principles present in the extract.(52) 
     
Materials and Methods: 
 Instrument   :  Agilent technologies 1220 infinity LC  
   (USA) 
 Coloumn    : Agilent Zorbax SB –C 18 
 Flow rate   : 1ml/minutes 
 Injection volume   : 10 µL 
 Detector     : UV-362 nm 
 
 Sample  :  EEPA     
   (0.1gm  in 100 mLof methanol) 
 Standard  : Apigenin (5 mg in 100 mL of  methanol) 
 Temperature   : 28 ºC  
 Mobile phase  : Methanol:acetonitrite:water (60:35:5) 
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The pH of the mobile phase was a adjusted to  pH 2.8 with the addition of phosphoric 
acid 
 Soft ware   : Open LAB ,CDS Chemistation work  
   station VL 
Linearity graph was genareted by plotting the  different concentration of the 
standard in the X axis (2.07, 4.13, 6.20, 8.26 ,10.33µg/mL)and the area of the peak in Y 
axis .The observed area of the standard was presented in the fig (23-29) 
The linear regression equation was calculated by Y= 101.4893 X 4.5210 and R2= 
0.9999.The result of the standard and sample chromatogram are presented in fig(23-29)  
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CHAPTER-VI  
PHARMACOLOGICAL SCREENING 
SECTION- A 
ANTIOXIDANT ACTIVITY.  
Plant derived antioxidants such as tannins, lignans, stilbenes, coumarins, 
quinones, xanthones, phenolic acids, flavones, flavonols, catechin, anthocyanins  and 
proanthocyanins could delay or prevent the onset of degenerative diseases because of 
their redox properties which allow them to act as hydrogen donors, reducing agents, 
hydroxyl radical scavengers and nitric oxide scavengers. 
Hydroxyl radical scavenging activity, β-Carotene – linoleic acid assay, DPPH 
method, Superoxide radical scavenging activity, Nitric oxide radical inhibition assay, 
Reducing power method, Phosphomolybdenum method, Peroxy nitrile radical scavenging 
activity, Xanthine oxidase method, Ferric reducing ability of Plasma and Thiobarbituric 
acid assay  are some of the methods for the evaluation of antioxidant activity.(53-54) 
Free radical scavenging activity using diphenyl picryl hydrazyl (DPPH) 
method (55-56) 
Principle  
Total antioxidant assays are used to compare the antioxidant activities of different 
molecules. DPPH is a stable free radical with a distinctive ESR signal. Its reaction with 
antioxidants can be followed by the loss of absorbance at 517 nm wavelength. It is widely 
accepted that DPPH can accept an electron or hydrogen radical to become a stable 
diamagnetic molecule. Due to its odd electron, the ethanol solution of DPPH, which is 
purple in colour shows a strong absorption at 517 nm. DPPH radicals react with suitable 
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reducing agents and then electrons become paired off and the solution loses colour 
stochiometrically with the number of electrons taken up. 
DPPH.  + AH →  DPPH-H  +  A. 
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents 
0.1mM diphenyl picryl hydrazyl in ethanol 
Procedure 
A stock solution of DPPH was prepared in 100mL of ethanol. To the 1ml of test 
samples of different concentrations, 4mL of DPPH was added. Control without test 
compound was prepared in an identical manner. In case of blank, DPPH was replaced by 
ethanol. The reaction was allowed to be completed in the dark for about 30min. Then the 
absorbance of test mixtures was read at 517 nm wavelength. The percentage inhibition 
was calculated and expressed as percent scavenging of DPPH radical. Vitamin C was 
used as standard. 
 The percentage scavenging was calculated using the formula [(Control-
Test)/Control] x 100 and the concentration of the sample required for 50% reduction in 
absorbance (IC50) was calculated using linear regression analysis.  
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Determination of scavenging activity against hydrogen peroxide (57) 
Principle  
The radical scavenging activity against hydrogen peroxide of plant extract was 
determined by using standard procedure .The principle is based the capacity on the 
extracts to decompose the hydrogen peroxide to water. 
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents 
6% Hydrogen peroxide diluted with water in the ratio of 1:10 
0.1M, pH 7.4 phosphate buffer . 
Procedure 
 To the 1mL of test solutions at different concentrations,  3.8mL of 0.1M 
phosphate buffer solution (pH 7.4) and  0.2mL of hydrogen peroxide solution were added. 
The absorbance of the reaction mixture was measured at 230 nm wave length after 10min. 
The reaction mixture without sample was used as blank. Sample blank was also prepared 
without reagents. Ascorbic acid was used as standard. The percentage inhibition of 
hydrogen peroxide was calculated using the formula      
% inhibition    =   (A control – A sample) / A control X 100 
The concentration of the sample required for 50 % reduction in absorbance (IC50) 
was calculated using linear regression analysis.The results and presented in table 13. 
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SECTION- B  
ANTICANCER EFFECT OF EEPA AGAINST DEN INDUCED 
HEPTOCELLULAR CARCINOMA IN RATS. 
Materials and methods  
CPSCEA approval 
The necessary approval for carrying out the study was obtained from the Animal 
Ethical Committee, K.M Collage of  Pharmacy, Uthankudi ,Madurai. 
Animals 
Wistar  albino rats weighing 180-200 g were used for the study. The animals were 
housed individually in polypropylene cages. Animals were acclimatized under standard 
laboratory conditions at 25± 2 °C and normal photoperiod (12h light: dark cycle). They 
were fed on normal pellet diet and water ad libitum.  
Chemicals and Reagents 
 Diethylnitrosamine (DEN) 
 Tris HCL buffer 
 Thiobarbituric acid (TBARS) 
 5,5 Dithiobis -2-nitro benzoic acid (DTNB) 
Diethylnitrosamine (DEN) was purchased from Sigma Chemicals and it  was 
dissolved in  normal saline and injected to rats as a single dose (200 mg/kg, i.p) to initiate 
hepatic carcinogenesis. 
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Experimental protocol 
The animals were divided into 4 groups and each group consists of six animals( 
n=6). Group I animals were administered 1% carboxy methyl cellulose( CMC)  for 7 
consecutive days by oral route. On the fifth day of experiment a single dose of DEN (200 
mg/kg /i.p) was administered  to DEN control (Group-II) animals. Group-III  and Group- 
IV animals were administered with EEPA (as a suspension in 1% CMC) at the dose of  
300 mg/kg b.w and 400 mg/kg b.w  respectively for 7 consecutive days by oral route. 
Group- III and Group-  IV animals were also  administered a single dose of DEN 
(200mg/kg /i.p.) on the fifth day of the experiment. 
Experimental  Design: 
Group Treatment 
I-Control Rats were administered 1ml of 1% CMC through oral route for 7 
consecutive days.  
II-DEN Control Rats were administered a single dose of DEN (200mg/kg, i.p) on 
the fifth day of the experiment. 
III -DEN + 
Extract(300 
mg/kg/oral) 
Rats were administered EEPA suspension (300 mg/kg b.w p.o) 
for 7 consecuvite days and a single dose of DEN(200mg/kg,i.p) 
was administered  on the fifth day of the experiment. 
IV-DEN+ 
Extract(400 
mg/kg/oral) 
Rats were administered EEPA suspension (400 mg/kg b.w p.o) 
for 7 consecuvite days and a single dose of DEN(200mg/kg,i.p) 
was administered  on the fifth day of the experiment. 
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At the end of the experiment, Blood sample was withdrawn for biochemical 
estimation from the   retro orbital plexus and the  animals were  sacrificed by cerivical 
dislocation (as per CPCSEA guidelines) and the liver was removed and used to study  the  
biochemical ,antioxidant and histopathological parameters. 
PARAMETERS TO BE EVALUATED                                                                              
 Serum biochemical parameters 
 Aspartate amino transaminase (AST) 
 Alanine transaminase (ALT) 
 Alkaline phosphatase (ALP) 
 Totalbilirubin and total protein 
 Lactate dehydrogenase(LDH)  
Estimation of in-vivo antioxidants in liver tissue homogenate 
 Thiobarbituric Acid Reactive Substances(TBARS) 
 Reduced Glutathione(GSH)   
 Histopathology of liver 
 ESTIMATION OF IN-VIVO ANTIOXIDANTS 
Preparation of tissue homogenate 
The isolated liver was washed and blotted in a filter paper. A 10 % tissue 
homogenate was prepared by using chilled 0.15 M Tris Hcl (PH 7.4) buffer and 
centrifuged at 5000 rpm for 5 minutes. The clear supernatant liquid was used for the 
estimation TBARS, GSH  and total protein. 
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Estimation of Lipid Peroxidation (TBARS)(58) 
Lipid peroxidation was estimated by using standard procedure  method described 
by Rajkumar  et al.  
To 1mL of tissue homogenate, 2.5mL of trichloroacetic acid 20 %(TCA) was 
added and centrifuge about 2.5mL of 0.05M sulphuric acid and 3.5mL th iobarbituric acid 
were added to the supernatant liquid and incubated at 370 C for 30 minutes. It was 
extracted with n-butanol. Intensity of the chromogen in the layer was measured at 530 nm 
wavelength using uv spectrophotometer. 
Estimation of reduced glutathions (59) 
Reduced glutathione was estimated by using standard procedure. 
1ml of tissue homogenate was precipitated with 1ml of 10 % TCA and was 
centrifuged to remove the precipitate. 0.5 ml of the supernatant , 2ml of 0.6 mM 5,5 
Dithiobis -2-nitro benzoic acid(DTNB) in 0.2 M sodium phosphate  was  added and the 
total volume was make upto 3ml with 0.2M phosphate buffer( pH 8). The absorbance was 
read at 412 nm wavelength. 
Histopathological studies 
Statistical analysis 
All the datas were expressed as standard error of mean (SEM). Data of 
biochemical parameters were analysed using one way ANOVA followed by Tukey’s 
multiple Kramer Comparison test. A value of p<0.05 was considered to be statistically 
significant.     
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CHAPTER VII 
RESULT AND DISCUSSION 
PHARMACOGNOSTICAL STUDIES 
Macroscopic studies 
The shape of the leaves are ovate. It is about 9 cm in length and 4cm in width. 
It bears entire  margin  and acute  apex . It has  reticulate venation . Dorsal surface of 
the leaves showed dark  green colour and the ventral surface bears light green 
colour.Taste is  astringent and it has characteristic odour. 
MICROCSOPICAL STUDIES 
Leaf 
The leaf consist of a thick plano-convex midrib and thin lamina (fig.9) The 
midrib  is slightly raised on the adaxial side and prominently semi circular on the 
abaxial side. The midrib is 580 µm thick and 750 µm wide. The epidermal layer of the 
midrib consists of squarish , thick walled cells. The ground tissue consists of angular 
thin walled compact parenchyma cells (fig.10). The vascular strand is wide and bowl 
shaped; it is collateral and includes several short parallel radial lines of xylem 
elements and thin continuos layer of abaxial phloem strands (fig.10). The xylem 
strands comprises four or five xylem elements arranged in radial multiples. The 
phloem elements are in small groups, distributed along this lower part of the xylem  
arc (fig11) .The meta xylem elements are about 15µm in diameter . 
FIG. 9
T.S. of Leaf through Midrib 
FIG. 10
T.S. of Midrib - Enlarged
Adaxial side
Vascular Strand
Lamina
Midrib
Abaxial Side
Adaxial side
Xylem
Phloem
Epidermis
Ground Tissue
FIG. 11
T.S. of Vascular Bundles of the Midrib
Xylem
Metax Xylem
Phloem
FIG. 12
T.S. of Lamina
FIG. 13
T.S. of Lamina - Enlarged view
Adaxial Epidermis
Palisade Mesophyll
Abaxial Epidermis
Spongy Mesophyll
Palisade Mesophyll
Adaxial EpidermisCuticle 
Abaxial Epidermis Spongy Mesophyll
FIG. 14
T.S. of Paradermal section of the lamina showing stomata
FIG. 15
T.S. of Stomata - Enlarged
Anti Clinal Walls
Epidermal Cells
Subsidiary
Cells
Stomata
Guard Cells
Subsidiary
Cells
FIG. 16
T.S. of Paradermal section of Adaxial part of the Lamina
Anticlinal walls
Epidermal Cells
FIG. 17
T.S. of Venation Pattern - Reticulate type
FIG. 18
T.S. of Vein - Islets and Vein Termination Enlarged
Vein-islets
Vein termination
Vein termination
Vein-islets
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Lamina  
The lamina is 100µm thick. The adaxial epidermal layer is nearly 20µm thick. 
The cells are (fig.12,13) squarish, thick walled and have thick  cuticle. The abaxial 
epidermis is slightly thin and the cells are cylindrical  or  squrish; the abaxial 
epidermal layer is stomatiferous. The mesophyll tissue is differentiated into adaxial 
band of a single layer of cylindrical palisade cells. The spongy parenchyma cells are 
small, spherical or lobed and form wide air spaces (fig.13). 
Epidermal Cells And Stomata 
The adaxial epidermal cells are polyhedral in outline. The anticlinal walls are 
thick and straight. The adaxial epidermis is apostomatic (fig .14,15,16). The abaxial 
epidermis consists of  squarish or polygonal cells. The anticlinal walls are thick, 
straight or slightly wavy (fig .14). The epidermis is stomatiferous.(fig.16) The stomata 
are paracytic type. The stomato has two subsdiary cells, which are located, one on 
either side and paralled to the guard cells (fig.15) The stoma is wide and elliptical is 
shape.The stomatal pore is narrowly elliptical.The stoma is 40 x 50 µm in size.  
Venation pattern 
The primary veins are thick and straight. The secondary and tertiary veins 
become gradually thin and they form distnict vein-islets. The vein-islets are wide and 
they very in shape and size (fig4:17) In the veins-islets , unbranched or branched once 
are repeatedly branched and dendroid vein-terminations. The vein terminations are 
slightly wavy (fig.18) The veins have thin paranchymatous sheath which encloses the 
veins throughtout their length. 
 
FIG. 19
Microscopical characters of powder of Phyllanthus acidus
Paracytic Stoma
Phloem
Sieve Tube
Companion Cells
VesselsParenchyma
Fibres
Collen
chyma
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Leaf- quantitative microscopy 
Leaf constants such as stomatal number, stomatal index, vein islet and vein 
termination were determined for the leaves of this plant and the results were tabulated 
in table  
Table 1 : Quantitative microscopical parameters of the leaf of  EEPA 
 
*mean of three readings ± SEM 
  
Powder analysis 
The behavior of P.acidus powder with various chemical reagents is tabulated 
in table2. It showed the presence of phytostreols, tannins, proteins,starch and  
compounds. 
 
 
S. No. Parameters Values* obtained 
1 Stomatal number  in upper epidermis 37±0.05 
2 Stomatal number  in lower epidermis 68±0.62 
3 Stomatal index in upper epidermis  19±0.27 
4 Stomatal index in lower epidermis  25±0.27 
5 Vein islet number 51±1.59 
6 Vein termination number 72±1.95 
7 Palisade ratio 9±0.27 
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Table 2: Behavior of the EEPA powder with various chemical reagents 
Powder + Reagents Colour / Precipitate Presence of active 
principle 
Picric acid Yellow precipitate Protein present 
Conc. sulfuric acid Reddish brown color Phyto sterols present 
Liberman Burchard reagent Reddish brown color Phyto sterols present 
Aqueous ferric chloride Greenish black color Tannins present 
Iodine solution Blue color Starch present 
Mayer’s reagent No cream color Absence of alkaloids 
Spot test No stain Fixed oils absent 
Sulfosalicylic acid White precipitate Protein present 
 
Fluorescence analysis 
The organic molecules absorb light usually over a specific range of wave 
length and many of them emit such radiations. So if the powder is treated with 
different chemical reagents and seen under UV light, different colours will be 
produce.(table-3). 
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Table: 3 Fluorescence analysis of powder of EEPA 
Powder +reagent Day light UV light (254 
nm) 
UV light (366 nm) 
Drug powder Green Green Brown 
Drug powder +aqueous 1M 
sodium hydroxide Green Green Brown 
Drug powder + alcoholic 1M 
sodium hydroxide Green Green Brown 
Drug powder + iodine Red Brown Brown 
Drug powder + 50% 
sulphuric acid Green Green Brown 
Drug powder+50% nitric 
acid Green Dark Green Brown 
 
Table: 4 Fluorescence analysis of extracts of EEPA 
Extract Consistency Colour in Day 
Light 
Colour under UV Lamp 
 366nm 254nm 
 Benzene 
extract 
Semisolid Yellow Orange Yellow 
Acetone 
extract 
Semisolid Yellow Reddish 
orange 
Green 
Ethyl acetate 
extract 
Semisolid Greenish brown Green Greenish -
brown 
Chloroform 
extract 
Semisolid Yellowish- brown Orange Yellowish 
brown 
Ethanolic 
extract 
Semisolid Yellowish green Orange Green 
Aqueous 
extract 
Semisolid Brown Green Dark green 
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The fluorescence characteristic of the drug powder with different chemical 
reagent was studied by observing under UV Light at 254 nm and 366 nm. The tests 
and observations are presented in table . 2  It suggested that a non-fluorescent 
compound may fluorescent if it mixed with impurities. The results obtained from the 
present fluorescent studies showed that the leaf powder of Phyllanthus acidus is 
devoid of any impurities.  
Loss on drying (LOD) 
The results obtained for the determination of LOD for this plant indicate that 
moisture content is within the limits and  presented in table-5 
The loss on drying of plant materials should be performed and the water 
content should also be checked. This is especially important for materials that absorb 
the moisture easily or deteriorate quickly in presence of water.  
Foreign matter 
The foreign matter present in the crude plant material of Phyllanthus acidus 
was determined and presented in table-5 
Drugs should be free from other than the specified parts, moulds, insects, 
animal faecal matter and other contaminations such as earth, stones and extraneous 
material. The amount of foreign matter is not be more than the percentage prescribed 
in the monograph. 
Ash value 
Total ash values, acid insoluble ash values and water soluble ash values were 
determined and presented in table-5. Result of this study showed that ash values are 
within the limits as prescribed in official texts .The total ash of a crude drug reflects 
the presence of inorganic salts such as silicates of sodium and potassium salts. The 
acid insoluble ash is a part of the total ash that is insoluble in dilute hydrochloric acid. 
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A higher limit of acid-insoluble ash indicates the presence of sand . Water-soluble ash 
is the water soluble portion of the total ash.  
 
Table: 5 Analytical parameters of EEPA 
S. No Parameters Values % w/w 
1. Foreign organic matter 0.02 ± 0.15 
2. Moisture content 3.47 ± 0.02 
3. Ash values  
 Total ash 1.77 ± 1.45 
 Acid insoluble ash 3.64± 0.45 
 Water soluble ash 3.38±0.90 
                                      *mean of three readings ± SEM  
Extractive values 
Extractive values were determined for the leaves of this plant material and the 
result are presented in table-6.The result of the study revealed that highest percentage 
of extractive values were noted as aqueous (19.80%) and hydro-ethanolic(15.56 %) 
extractives and it indicates the presence of  more polar  constituents present in the 
plant material. Table-6. 
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Table 6: Analytical parameters-Extractive values of EEPA 
 S.NO Parameters* Values* expressed as % 
1. Extractive Values  
 Ethyl acetate extract 15.11% 
 Acetone extract 13.5%            
 Chloroform extract 1.51% 
 Hydro-ethanolic 
extract(Ethanol:water,70:30)
16.56% 
 Benzene extract 11.53% 
 Aqueous extract 19.80% 
 
 PHYTOCHEMICAL SCREENING 
Collection, authentication  and preparation of extract have been discussed in 
this chapter. Powdered plant material and various extracts were subjected to 
preliminary phytochemical studies which indicates the presence of flavonoids, 
tannins, phenols. The preliminary phytochemical studies also showed that the 
presence of almost all phytoconstituents  viz. flavonoids , phenol, tannins, 
phytosterols ,triterpenoids and carbohydrates. The 70% ethanolic extract of this drug 
showed highest extractive value and also showed the presence of therapeutically 
viable phytoconstituents. Hence it has been chosen for the phytochemical and 
pharmacological studies. 
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Table-7 Preliminary phytochemical screening for the leaf powder of EEPA 
S.NO TEST RESULTS 
1. Test for sterols  
 a. Salkowski’s test + 
 b. Libermann- burchard’s test + 
2. TEST FOR CARBOHYDRATES  
 a. Molisch’s test + 
 b. Fehling’s test + 
 c. Benedict’s test + 
3. TEST FOR PROTEINS  
 a. Millon’s test + 
 b. Biuret test + 
4. TEST FOR ALKALOIDS  
 a. Mayer’s reagent - 
 b. Dragendroff’s reagent - 
 c. Hager’s reagent - 
 d. Wagner’s reagent - 
 e. Test for Purine group (Murexide test ) - 
5. TEST FOR GLYCOSIDES  
 a. Anthraquinone glycosides  
 i) Borntrager’s test - 
 ii) Modified Borntrager’s test - 
 b. Cardiac glycosides  
 i) Keller Killiani test - 
 c. Cyanogenetic glycosides - 
 d. Coumarin glycosides  
6. TEST FOR SAPONINS - 
7. TEST FOR TANNINS  
 Fecl3 test + 
8. TEST FOR FLAVONOIDS  
 a. Shinoda test + 
 b. Alkali test + 
 c. Acid test + 
9. TEST FOR TERPENOIDS + 
10. TEST FOR VOLATILE OILS - 
11. TEST FOR MUCILAGE - 
                  (+) indicates positive reaction                 (-) indicates negative reaction 
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Table 8: Preliminary Phytochemical Screening for the various extracts  
of leaf powder of EEPA 
Tests Benzene 
Extract 
Ethyl 
acetate 
extract 
Chlorofor
m  extract 
Acetone 
Extract 
Ethanol 
Extract 
1. Test For Sterols 
a. Salkowski’s test + + + + + 
b.Libermann-Burchard’s 
test + + + + + 
2. Test for carbohydrates 
a. Molisch’s test - - - + + 
b. Fehling’s test - - - + + 
c. Benedict’s test - - - + + 
3.Test for protein 
a. Millon’s test - - - + + 
b. Biuret test - - - + + 
3.Test for Alkaloids -     
a.Mayer’s reagent - - - - - 
b. Dragendroff’s reagent - - - - - 
c. Hager’s reagent - - - - - 
d. Wagner’s reagent - - - - - 
e. Test for purine group 
(Murexide test) - - - - - 
4.Test for glycosides 
a.  Anthraquinone     
     glycosides 
-     
     i) Borntrager’s test - - - - - 
   ii) Modified Borntrager   
         test - - - - - 
b. Cardiac glycosides -     
    i) Keller Killiani test  - - - - - 
    ii) Baljet test -    - 
   iii) Cyanogenetic  
glycosides - - - - - 
   iv) Coumarin glycosides - - - - - 
VI. Test for Saponins - - - - - 
VII. Test for Tannins 
i) FeCl3 test  - - - + + 
ii)lead acetate test - - - + + 
VIII. Test for Flavonoids 
a. Shinoda test - + - + + 
b. Alkali test - + - + + 
IX. Test for Terpenoids + + + + + 
      
 (+) indicates positive reaction                 (-) indicates negative reaction   
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Determination of phenolic content 
Table 9 Total phenolic content of ethanolic extract of EEPA 
S. 
No. 
Conc. of 
gallic 
acid in 
µg/mL 
Absorbance at 
760nm 
Conc. of 
ethanolic 
extract in 
µg/mL 
Absorbance 
at 760nm* 
Amount of total 
phenolic content 
in terms 
mgGAE/g of 
extract* 
1 2 0.229 ± 0.010 50 0.260±0.012 46.39±0.63 
2 4 0.452 ± 0.006 100 0.568±0.003 50.3±0.54 
3 6 0.695 ± 0.005  
Average 48.34±0.5 4 8 0.918 ± 0.031  
5 10 1.162 ± 0.028  
* mean of three readings ±SEM 
In the present study, total phenolic content present in EEPA was estimated using 
modified Folin- ciocalteau method. Values are expressed as gallic acid equivalents 
and the results were tabulated(60.) The linear regression equation was found to be 
y=0.116x-0.004 while the correlation was found to be 0.9998. The amount of phenolic 
content present in the extract in terms of mg GAE/g of extract was found to be 
48.34mg/g by using the above linear regression equation. 
Polyphenols are the important secondary metabolites with high level of 
antioxidant activity. This activity could be due to their ability to absorb, neutralize 
and to quench free radicals.(57) Their ability  to act as free radical scavenger could also 
be attributed due to their redox properties, presence of conjugated ring structures and 
carboxylic group which have been reported to inhibit lipid peroxidation. (61)The 
results indicate that the EEPA showed the significant phenolic content and the 
phenolic constituents  has already been reported  for  anticancer activity. 
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.FIG-20Calibratiocurveforgallic acid 
Calibration curve of gallic acid
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Determination of flavonoid content 
Table 10  Total flavonoid content of ethanolic extract of EEPA 
 
S. 
No. 
Conc. of 
querceti
n in 
µg/mL 
Absorbance 
at 415nm 
Conc. of 
ethanolic 
extract in 
µg/mL 
Absorbance at 
415nm 
Amt of total flavonoid 
content in terms of mg 
quercetin equivalent/ 
g of extract 
1 20 0.589 ± 0.01 50 0.058±0.003 32.38±0.75 
2 40 1.151 ± 0.04 100 0.150±0.007 33.16±0.16 
3 60 1.710 ± 0.09  
Average 32.77±0.4 4 80 2.390 ± 0.03  
5 100 3.112 ± 0.03  
*mean of three readings ± SEM 
Total flavonoid content for EEPA was found to be 32.77mg/g . The linear 
regression equation was found to be y = 0.0307x - 0.0432 while the correlation was 
found to be 0.9974.  Flavonoids play an important role in plants, such as 
pigmentation, protection against UV-radiation, reproduction, and regulation of plant 
growth. Flavonoids have shown significant ROS scavenging activity as compared to 
vitamin C and carotenoids(57) Its antioxidative activity is depends on the chemical 
structure, such as the number of hydroxyl groups substituted on the B ring. Intake of 
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Calibration curve of quercetin
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flavonoids has been associated with reduced the incidences of cancer, heart disease 
and various neurological disorders. 
 
 
      
 
 
 
 
 
        FIG.21: Calibration curve of quercetin 
. 
Total Tannin Content: 
Table 11 Total tannin content in ethanolic extracts of EEPA in terms of Tannic 
acid equivalents 
S.No. 
Conc. of 
Tannic 
acid in 
µg/mL 
Absorbance 
at 700nm 
Conc. of 
ethanolic 
extract in 
µg/mL 
*Absorbance 
at 700nm 
*Amt of total Tannin 
content in terms mg tannic 
acid equivalent/ g of 
extract 
1 20 0.589 ± 0.01 20 0.132±0.04 197.7±0.12 
2 40 1.151 ± 0.04  
  
3 60 1.710 ± 0.09 
4 80 2.390 ± 0.03 
5 100 3.112 ± 0.03 
    Average 98.85±0.06 
Total tannin content of EEPA was found to be 98.85 mg/g .The linear regression 
equation was found to be y = 0.022x + 0.003 while the correlation was found to be 0.999. 
Tannin are antioxidant phytocontituents. 
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FIG- 22   Calibration curve for Tannic acid 
                         
         
Identification and estimation of apigenin in EEPA by HPLC  
The results of the HPLC chromatogram of standard apigenin and EEPA 
extract are presented in (FIG.23-29)   HPLC  chromatogram revealed that  the 
retention time (tR)  of standard apigenin was found to be 13.85 mints  (tR). The 
retention of  a  peak appeared  in the chromatogram of EEPA extract was found to be  
13.88 mints  (tR) and it indicates the presence of apigenin in the EEPA extract. The 
percentage content of apigenin present in the air dried leaf plant material of EEPA 
was calculated as 0.042% So for apigenin has not been reported in this plant, but it 
has been reported in other species of this plant.. 
 
 
 
 
 
 FIG:23.  HPLC chromatogram of  EEPA 
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FIG:24. HPLC chromatogram of apigenin(10.33 MCG/ML) 
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Name RT[min] Area Area % TP TF
APIGENIN 13.85 1041.13 100.00 5772 1.73
 Sum 1041.13 100.00
 
 FIG:25. HPLC chromatogram of apigenin (8.26 MCG/ML)  
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Name RT[min] Area Area % TP TF
APIGENIN 13.85 838.12 100.00 6253 1.80
 Sum 838.12 100.00
 
 FIG:26 HPLC chromatogram of apigenin(6.20MCG/ML) 
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Name RT[min] Area Area % TP TF
APIGENIN 13.85 624.26 100.00 6435 1.84
 Sum 624.26 100.00
 
 FIG:27. HPLC chromatogram of apigenin (4.13 MCG/ML) 
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Name RT[min] Area Area % TP TF
APIGENIN 13.87 414.87 100.00 6501 1.86
 Sum 414.87 100.00
 
 FIG:28. HPLC chromatogram of apigenin (2.07 MCG/ML) 
  
Analysed by:                                                                                        Checked by:  Page 0 of 1 
     
 
 
 
 
 
 
 
Name RT[min] Area Area % TP TF
APIGENIN 13.89 204.32 100.00 6551 1.89
 Sum 204.32 100.00
 
 FIG:29.HPLC chromatogram of EEPA 
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Name RT[min] Area Area % TP TF
 2.62 391.58 17.73 894 0.85
 2.87 74.48 3.37 19 0.81
 3.00 190.50 8.63 280 1.10
 3.41 538.25 24.37 573 1.03
 3.83 261.84 11.86 3101 1.33
 4.33 123.15 5.58 2535 0.90
 4.97 44.29 2.01 3234 0.86
 7.57 61.56 2.79 4839 1.30
APIGENIN 13.88 522.80 23.67 5509 1.68
 Sum 2208.45 100.00
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PHARMACOLOGICAL SCREENING 
SECTION-A 
Antioxidant activity 
DPPH radical scavenging activity 
Table- 12  DPPH radical scavenging activity of (EEPA) 
 
S. No. Conc. in 
μg/mL 
Percentage 
inhibition by 
standard ascorbic 
acid 
Percentage 
inhibition by 
ethanolic extract 
1 20 25.86 ± 5.63 22.99 
2 40 53.32 ± 4.84 48.98 
3 60 62.2 ± 7.35 56.71 
4 80 81.21 ± 5.87 67.84 
5 100 93.73 ± 0.85 69.98 
 IC50 47.04μg/mL   51.99µg/mL 
DPPH is a stable free radical and accepts an electron or hydrogen radical to 
become a stable diamagnetic molecule (61) In the DPPH assay, the antioxidants are 
able to reduce the stable radical DPPH to non-radical form, DPPH-H. The purple 
colour alcoholic solution of DPPH radical changes to yellow colour which could be 
measured at 517 nm. 
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Ascorbic acid is used as a standard.The radical scavenging activity of ascorbic 
acid and EEPA increases in a dose-dependent manner and the results are tabulated in 
table-13. IC 50 of ascorbic acid and EEPA were found to be 47.04 µg/ml and 
51.99µg/ml respectively.  
FIG:30. Free radical scavenging activity of EEPA and standard ascorbic 
acid against DPPH 
 
 
Hydrogen peroxide scavenging activity assay: 
Table-13. Free radical scavenging activity of EEPA  
S. No. Conc. in 
μg/mL 
Percentage inhibition by 
standard ascorbic acid 
Percentage inhibition 
by EEPA 
1 20 18.81± 0.12 16.04 
2 40 23.52± 0.28 21.31 
3 60 47.85± 0.11 43.63 
4 80 72.18± 0.54 65.79 
5 100 86.56± 0.39 82.14 
 IC50 47.04µg/ml 55.97µg/ml 
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Hydrogen peroxide has strong oxidizing properties. It can be formed invivo by 
many oxidizing enzymes, such as superoxide dismutase and can cross cellular 
membranes and may slowly oxidize a number of intracellular compounds. It has been 
shown that the IC50 of EEPA was found to be 55.97µg/ml when compared to standard 
ascorbic acid 47.04µg/ml.  
FIG:31. Free radical scavenging activity of EEPA standard ascorbic acid 
against Hydrogen peroxide 
 
Discussion 
    This study showed the EEPA exhibited significant free radical scavenging activity;   
phenolic constituents such as flavonoids and tannins  present in this extract may be 
attributed for this activity. Phenolic OH groups present in these phytoconstituents 
spares hydrogen atoms for free radical scavenging activity.(61)This study revealed that 
the significant  anti oxidant activity of these extracts.  
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SECTION-B 
Anticancer activity of EEPA against DEN induced liver cancer 
  This part of the pharmacological studies has dealt with anticancer effect of 
EEPA against in DEN induced liver carcinoma in rats. Biochemical parameters such 
as serum ALT(ALANINE TRANSAMINASE) AST(ASPARTATE AMINO 
TRANSAMINASE) ALP(ALKALINE PHOSPHATASE) and bilirubin and liver 
tissue homogenate TBARS and GSH were estimated and the results are presented in 
table-14. The histopathological studies  were carried out in liver tissue in order to 
ascertain the induction of liver carcinoma in rats by the administration of DEN.  
 Effect of EEPA on biochemical parameters  
Table 14. The effect of EEPA extract on liver tissue biomarker changes 
Groups 
AST 
(IU/L) 
ALT 
(IU/L)        
ALP 
(IU/L) 
Bilirubin 
(mg/dl) 
LDH 
(IU/L) 
Liver weight 
(g) 
Total Protein 
(mg / g wet 
tissue) 
GSH 
(µg / mg 
of 
Protein) 
TBARS 
(nmol/mg of 
Protein) 
Control 114.5 ± 1.3 44.7 ± 1.2 189.2 ± 1.8 0.5 ± 0.2 79.4 ± 0.9 4.6 ± 0.7 69.2 ± 1.1 3.2 ± 0.3 0.35 ± 0.02 
DEN 259.8 ± 1.1  202.5 ± 0.7  395.2 ± 2.3  3.5 ± 0.6 a 147.8 ± 1.4  8.2 ± 1.1 a 49.6 ± 1.4 a 1.7 ± 0.2 a 0.62 ± 0.03 a 
EEPA 
(300)   
171.2 ± 0.9  142.9 ± 1.2  309.6 ± 2.6  1.1 ± 0.5 a 129.5 ± 1.1  6.3 ± 0.9 a 64.9 ± 0.9 b 2.1 ± 0.4 a 0.53 ± 0.02 a 
EEPA (400)   135.7 ± 1.2b 56.9 ± 0.8 b 219.9 ± 2.2  0.6 ± 0.4 b 83.9 ± 1.5 b 5.1 ± 0.8 b 67.8 ± 0.6 b 3.1 ± 0.3 b 0.39 ± 0.04 b 
 
Digits in parenthesis indicate dose in mg/kg. 
Data were expressed as mean ± SEM, n= 6 rats per group. aP < 0.05 vs control group. 
bP < 0.05 vs DEN treated group. 
 a- DEN control compared with control group 
b- EEPA 300mg/kg and  EEPA 400mg /kg compared with  DEN control group 
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Statistical significance test comparison was done by  one way ANOVA 
followed by Tukey -Kramer multiple comparison test 
Serum biochemical parameters 
The effect of DEN and EEPA treatment on serum liver function markers like 
ALT, AST, ALP, LDH ,total bilirubin and total protein of experimental rats are as 
follows: 
Administration of   DEN to Group II animals caused  significant increase in 
serum ALT, AST, ALP, LDH  and bilirubin and decreases the level of  total protein 
when compared to the(control) Group I animals (P<0.05).  Treatment of  EEPA at 
400mg/kg b.w p.o  to Group IV animals attenuated DEN induced elevated serum 
ALT, ALP ,AST, LDH and total bilirubin (P<0.05)and increases the  total protein 
level(P<0.05) But treatment of   EEPA at 300mg/kg b.w p.o  to Group III animals did 
not modify the DEN induced biochemical abnormalities significantly. 
In vivo antioxidant parameters 
Animals treated with DEN and EEPA caused alteration of oxidative stress 
biomarker  TBARS and endogenus antioxidant GSH in liver tissue homogenate and 
the results are presented in table-24. DEN administration to group II animals modified 
the significant  increase in TBARS level and a significant decrease in GSH level as 
compared to the Group I( control) animals  (P<0.05). Group IV animals treated with 
EEPA at (400mg/kg b.w p.o)  caused the significant attenuation of DEN induced 
elevated TBARS  level and  augmented the  GSH level (P<0.05). But treatment of   
EEPA at (300mg/kg b.w p.o ) to Group III animals did not restore the DEN induced  
antioxidant imbalance significantly. 
Chapter – VII                                                                        Result and Discussion 
 
Department of Pharmacognosy, MMC, Madurai                                                   Page 61 
 
Liver weight  
Animals treated with DEN caused changes in liver weight and the results are 
presented in table-14 DEN administration to group II animals caused an  increase in  
liver weight  when compared to the Group I animals (control) (P<0.05). Group IV 
animals treated with EEPA at (400mg/kg b.w p.o)  significantly decreased the liver 
weight (P<0.05). But treatment of   EEPA at 300mg/kg b.w p.o  to Group III animals 
did not decrease the liver weight significantly. 
Histopathological study 
The histopathological changes of liver tissue induced by DEN in normal and 
EEPA treated rats are as follows; 
Group I animals (control) showed  normal liver histology with no signs of 
liver injury and this was indicated by  normal hepatic nodules and central vein.  
Group II animal treated with DEN showed clear signs of severe hepatic injury. 
Hepatocytes were manifested with periportal and perivascular inflammatory infiltrates 
with diffuse ballooning degeneration and proliferation of vascular channels are also 
noted in several areas. Binucleation and acidophilic bodies were also focussed 
Group III animals treated with EEPA (300mg/kg b.w p.o) and DEN showed 
hepatic injury and manifested with periportal inflammation with conspicuously 
dilated blood vessel and ballooning degeneration. 
Group IV animals treated with EEPA (400/kg b.w p.o) and DEN showed mild 
hepatic injury and manifested with minimal periportal inflammation. 
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Discussion 
Diethyl nitrosamine (DEN) is an important environmental carcinogen that 
primarily induce tumor of the liver, because of its relatively simple metabolic 
pathway and potent carcinogenic activity(62). DEN exhibited its carcinogenicity 
through the metabolic activation in the liver microsomes causing the release of 
alkylating agents that binds to the DNA forming adducts. (63)Lipid peroxidation (LPO) 
is considered as one of the basic mechanism of cellular damage induced by free 
radicals. Free radicals react with lipids causing peroxidation resulting in release of 
malandioldehyde (MDA), hydrogen   peroxide (H2O2) and hydroxyl radicals (OH). 
ROS (Reactive oxygen species ) including oxygen, hydrogen peroxide and hydroxyl 
radicals (OH) play an important role in carcinogenesis. . 
 DEN administration caused the elevation of liver function markers including 
ALT, AST, ALP ,LDH and total bilirubin and severe histopathological lesions were 
noted in liver tissues.  
The elevation of ALT, AST and ALP  indicated hepatocellular damage in the 
DEN  administered rats. In the  present  study, the observed increase in serum indices 
of liver function by DEN could be a secondary event following DEN-induced lipid 
peroxidation of hepatocyte membranes with the consequent increase in the leakage of 
ALT, ALP, AST and total bilirubin from liver tissues. An elevated level of serum 
indices of hepatocellular damage has been previously reported in many models of 
DEN-induced hepatocellular degeneration..LDH is a tumour marker. Elevated LDH 
level were noted in the DEN administered rats. Treatment of EEPA at 400mg/kg 
significantly decrease this tumour marker.  
Chapter – VII                                                                        Result and Discussion 
 
Department of Pharmacognosy, MMC, Madurai                                                   Page 63 
 
There are evidences to support that oxidative stress is an important component 
of carcinogenesis and clear examples of the participation of ROS in 
hepatocarcinogenesis in rats.  There was an abnormal increase of LPO in the present 
study in the cancer bearing rats when compared to control. It was indicated by the 
elevation of TBARS which is the marker compound of LPO. This might be due to 
oxidative stress induced free radical(64) mediated changes by DEN. The decreased 
level of LPO in plant extract treated animals may be attributed due to free radical 
quenching effect of EEPA 400 mg/kg.It was indicated by the decreased level of 
TBARS. 
GSH is a well known non enzymic antioxidant defense system of cells. It has 
been shown to offer protection against super oxides as well as H2O2 and it contributes 
to membrane stability. It is said to be involved in many cellular processes including 
detoxification of endogenous and exogenous compounds. Decreased level of GSH has 
been reported in patients with liver diseases of alcoholic, non-alcoholic, viral and 
other etiology. DEN, an electrophilic carcinogen may interact with the large 
nucleophilic pool of GSH thereby reducing the macromolecules and carcinogen 
interaction. Glutathione is a potent inhibitor of the neoplastic process, plays an 
important role in the endogenous anti-oxidant systems. The  decreased GSH  level in 
DEN  administered rats  were noted in the present study. Treatment with EEPA 
(400mg/kg)     showed elevation of GSH level. 
Preliminary phytochemical studies indicate the presence of  phenolic 
constituents such as flavonoids, tannins,sterol and protein  in EEPA. HPLC studies 
revealed the presence of apigenin in EEPA..Flavonoids are known to possess 
hepatoprotective activity and apigenin was reported for the treatment of hepatocellular 
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carcinoma  Flavonoids have are already been reported for the elevation of GSH and 
suppress the TBARS level in various animal model. 
 EEPA showed the potential invitro antioxidant activity by DPPH assay and 
hydrogen peroxide scavenging activity. These plant extracts also exhibited invivo 
antioxidant activity by elevating endogenus antioxidant GSH and suppress the 
TBARS in liver tissue homogenate.  Both in vitro and in vivo antioxidant pontential of  
EEPA may be attributed for the  anticancer activity against the DEN induced 
hepatocellular carcinoma.(65) 
 
  
Chapter – VIII                                                                               Summary and Conclusion 
 
Department of Pharmacognosy, MMC, Madurai                                                              Page 65 
SUMMARY AND CONCLUSION 
Phyllanthus acidus belonging to the family euphorbiaceae was evaluated for 
pharmacognostic, phytochemical studies including quantification of apigenin by HPLC 
analysis, in vitro  anti oxidant activity and DEN induced liver cancer studies  in rat model. 
The macroscopical and microscopical characters, physical standards like ash values, 
extractive values, loss on drying, foreign organic matter and fluorescence analysis have 
been studied in order to standardize the leaves of this plant  The gist of the finding 
derived from the investigations of this project is furnished in the following concluding 
lines. 
Pharmacognostical parameters have been determined for the leaf of phyllanthus 
acidus in order to substantiate and identify the plant for future work. 
Preliminary phytochemical screening of the leaf phyllanthus acidus confirms the 
presence of sterols,terpenoids,carbohydrates ,proteins,flavonoids,tannins and 
phenols.Total phenolic content(48.34mg/g,)total flavonoid content(32.77mg/g) total 
tannin content(98.85mg/g) were determined for  EEPA extract by UV Spectrophotometric 
method. 
HPLC study was performed for EEPA extract revealed that the tR of the standard 
(apigenin) and sample were found to be 13.88 mins and 13.85mins respectively and this 
study indicates the presence of apigenin in the extract. Apigenin present in this exract was 
also quantified as 0.042% . The  presence of apigenin has not been reported from the  
leaves of this plant.This is the first time we have reported the presence of apigenin from 
the leaves of this plant . 
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Pharmacological screening confirms that EEPA exhibited the potent radical 
scavenging activity by both  DPPH and hydrogen peroxide assay methods and the IC 50 
Values were foud to be 47.04 µg/mL and 51.99 µg/mL of  EEPA respectively.The  free 
radical scavenging activity may be attributed due to the presence of  flavonoid 
constituents like apigenin.  
EEPA exhibited the significant anticancer activity against diethyl nitrosamine 
induced liver cancer in rats treated at the dose of 400 mg/kg, where as the treatment of 
300 mg/kg did not show significant anticancer activity. Anti cancer activity of EEPA 
against the DEN  induced liver cancer may be due to the presence of antioxidant 
phytoconstiuents like flavonoids. Apigenin present in this extract has been reported for 
hepatocellular carcinoma. Oxidative stress is the basic mechanism behind carcinogenesis. 
EEPA exhibited significant anticancer activity by virtue of its anti oxidant activity and 
this may be due to the presence of apigenin. 
Future scope of the study 
The active principles responsible for liver cancer may be isolated and evaluated 
for this activity cancer studies using different animal model.This extract and the isolated 
active principles may be formulated in suitable dosage form and they may be launched in 
the market. These herbal formulations will be beneficial to the  liver cancer  patients  
those who are  not affordable to  treat with allopathic chemotherapeutic agents. Sorafenib 
is the only drug which is used for the chemotherapy of liver cancer. It will not cure the 
liver cancer but increases the survival of the patient for only six months and for this 
treatment the patient has to spent lakhs of rupees.  
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